Spondyloarthritis & psoriatic arthritis
Difficult-to-treat psoriatic arthritis (D2T psoriatic arthritis (PsA)): a scoping literature review informing a GRAPPA research project
Authors' conclusion
The definitions and criteria for D2T PsA and for 'active disease' are notably heterogeneous, with considerable variation across sources.
Study context
- Population
- Studies defining D2T PsA: PubMed (English, full text, past decade), ACR Convergence 2022, EULAR Congress 2023, Google Scholar and cited articles; search July 202315 studies from 565 references
- Participants
- 15 studies
- Outcome
- Definitions and criteria of difficult-to-treat (D2T) PsA in the literature
Methodological detailsPRISMA-ScR guidelines, two independent reviewers, conflicts adjudicated by a third
- PRISMA-ScR guidelines
- Two independent reviewers, conflicts adjudicated by a third
Main finding
As reported in the abstract
Definitions of 'active disease' and 'resistant PsA'
- Considerable variations in defining both 'active disease' and 'resistant PsA', most often termed 'D2T' PsA
Original publication
Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project. RMD Open. Published 8 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →